ACAMPROSATE CA 333MG TAB NATIONAL CMOP

SOL #: 36C77026Q0092Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NATIONAL CMOP OFFICE (36C770)
LEAVENWORTH, KS, 66048, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 25, 2026
2
Last Updated
Feb 27, 2026
3
Submission Deadline
Mar 4, 2026, 10:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the National CMOP Office, is soliciting quotations (RFQ 36C77026Q0092) for the procurement of ACAMPROSATE CA 333MG EC TAB 180CT. This is an Unrestricted Procurement for delivery to multiple VA CMOP facilities. Quotations are due by March 4, 2026, at 4:00 PM CDT.

Scope of Work

This opportunity requires the supply of ACAMPROSATE CA 333MG EC TAB 180CT (National Stock Number: 68462-0435-18) to various VA CMOP facilities, including Chelmsford, Tucson, Lancaster, Murfreesboro, Hines, and Charleston. Deliveries will be staggered monthly over a three-month period, with the first delivery required 10 days after receipt of order.

Key Requirements

  • Product Specifications: Products must have a therapeutic equivalence code of "A" by the FDA (unless all drugs in the family group are "B" rated), and expiration dates must be no less than 12 months from the date of delivery.
  • Packaging: Bar code labeling conforming to GS1-128 or HIBCC standards is required at the unit-of-use package level. Packages below 500 count require a Safety/Child Proof cap, and minimum bottle size is 100cc with a child safety cap and cylindrical body.
  • Compliance: Vendors must provide Drug Supply Chain Security Act (DSCSA) compliance documentation (Transaction History, Transaction Information, Transaction Statement) for prescription pharmaceuticals. Only TAA compliant NDCs will be accepted unless no TAA product is available.

Contract Details

  • Opportunity Type: Request for Quotation (RFQ)
  • Set-Aside: Unrestricted Procurement (Full and Open Competition)
  • NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing) with a size standard of 1300 employees.
  • Product Service Code: 6505 (Drugs And Biologicals)

Submission & Evaluation

  • Submission Deadline: March 4, 2026, at 4:00 PM CDT.
  • Submission Method: Quotes must be emailed to sarah.fry2@va.gov.
  • Required Documents: A complete submission must include a signed RFQ cover page (SF 1449), a completed Excel pricing schedule (including Place of Manufacture), a valid State Wholesale Distributor License, and a completed Trade Agreements Act (TAA) Certificate (Section E).
  • Evaluation Factors: Quotes will be evaluated based on Technical, Past Performance, Delivery, and Price. The government reserves the right to consider quotations other than the lowest price if they offer additional benefit.
  • Vendor Requirements: Offerors must be registered and current in SAM.gov and agree to hold prices firm for 30 calendar days.

Additional Notes

Tracking information for shipments must be emailed to cynthia.triebel@va.gov. Vendors must provide a firm commitment of product availability and price 24 hours prior to purchase order.

People

Points of Contact

Files

Files

Download
Download
Download
Download
Download

Versions

Version 3Viewing
Solicitation
Posted: Feb 27, 2026
Version 2
Solicitation
Posted: Feb 25, 2026
View
Version 1
Pre-Solicitation
Posted: Feb 25, 2026
View
ACAMPROSATE CA 333MG TAB NATIONAL CMOP | GovScope